Tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile
C105H117BBrN19O9 — CID 158726292
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile
Tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile (PubChem CID 158726292) has the molecular formula C105H117BBrN19O9 and a molecular weight of 1879.93 g/mol. Its IUPAC name is tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile.
Molecular Properties
| Compound Name | Tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile |
|---|---|
| PubChem CID | 158726292 |
| Molecular Formula | C105H117BBrN19O9 |
| Molecular Weight | 1879.93 g/mol |
| Exact Mass | 1877.86 |
| IUPAC Name | tert-butyl 4-(4-bromo-2-piperidin-1-ylbenzoyl)piperazine-1-carboxylate;tert-butyl 4-[4-[3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl]-2-piperidin-1-ylbenzoyl]piperazine-1-carboxylate;4-[6-[4-(piperazine-1-carbonyl)-3-piperazin-1-ylphenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile;4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzonitrile |
| SMILES | CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc(C#N)cc5)n4c3)cc2N2CCCCC2)CC1.CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(Br)cc2N2CCCCC2)CC1.CC1(C)OB(c2ccc3ncc(-c4ccc(C#N)cc4)n3c2)OC1(C)C.N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCNCC5)c(N5CCNCC5)c4)cn23)cc1 |
| InChI | InChI=1S/C35H38N6O3.C29H29N7O.C21H30BrN3O3.C20H20BN3O2/c1-35(2,3)44-34(43)40-19-17-39(18-20-40)33(42)29-13-11-27(21-30(29)38-15-5-4-6-16-38)28-12-14-32-37-23-31(41(32)24-28)26-9-7-25(22-36)8-10-26;30-18-21-1-3-22(4-2-21)27-19-33-28-8-6-24(20-36(27)28)23-5-7-25(29(37)35-15-11-32-12-16-35)26(17-23)34-13-9-31-10-14-34;1-21(2,3)28-20(27)25-13-11-24(12-14-25)19(26)17-8-7-16(22)15-18(17)23-9-5-4-6-10-23;1-19(2)20(3,4)26-21(25-19)16-9-10-18-23-12-17(24(18)13-16)15-7-5-14(11-22)6-8-15/h7-14,21,23-24H,4-6,15-20H2,1-3H3;1-8,17,19-20,31-32H,9-16H2;7-8,15H,4-6,9-14H2,1-3H3;5-10,12-13H,1-4H3 |
| InChIKey | IKNSBRKPNCNZHJ-UHFFFAOYSA-N |
| XLogP | 16.52 |
| TPSA | 295.52 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 23 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 135 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1879.93 |
| LogP ≤ 5 | 16.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 23 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158726292 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.